Annex

United Kingdom

The purity indicated in this column was the minimum degree of purity of the active substance evaluated in accordance with Article 89(1) of Regulation (EU) No 528/2012. The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.
Common Name	IUPAC NameIdentification Numbers	Minimum degree of purity of the active substance^f1	Date of approval	Expiry date of approval	Product type	Specific conditions
Citric acid	IUPAC Name: 2-hydroxy-1,2,3-propanetricarboxylic acid EC No: 201-069-1 CAS No: 77-92-9	995 g/kg	1 March 2018	28 February 2028	2	The authorisations of biocidal products are subject to the following condition: The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.

The purity indicated in this column was the minimum degree of purity of the active substance evaluated in accordance with Article 89(1) of Regulation (EU) No 528/2012. The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.

Common Name

IUPAC NameIdentification Numbers

Minimum degree of purity of the active substance^f1

Date of approval

Expiry date of approval

Product type

Specific conditions

Citric acid

IUPAC Name:

2-hydroxy-1,2,3-propanetricarboxylic acid

EC No: 201-069-1

CAS No: 77-92-9

995 g/kg

1 March 2018

28 February 2028

The authorisations of biocidal products are subject to the following condition:

The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.

Annotations

Footnotes

f1: The purity indicated in this column was the minimum degree of purity of the active substance evaluated in accordance with Article 89(1) of Regulation (EU) No 528/2012. The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.